Maze Therapeutics Inc

MAZE

Healthcare|Biotechnology|USA

$30.56

-1.89 (-5.82%)

Tangible Book

$6.87

Upcoming Data Readouts (1)

Dec 2027

Est. completion

P2Phenylketonuria (PKU)

A Phase 2 Study of MZE782 in Adults With PKU

NCT07694440n=38

Recent Press Releases